Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $37.98 and traded as high as $40.00. Pro-Dex shares last traded at $39.48, with a volume of 17,328 shares traded.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “hold (c)” rating on shares of Pro-Dex in a report on Monday, December 29th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $56.00.
Get Our Latest Stock Analysis on Pro-Dex
Pro-Dex Stock Performance
Pro-Dex (NASDAQ:PDEX – Get Free Report) last issued its quarterly earnings results on Thursday, January 29th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the consensus estimate of $0.59 by $0.07. The business had revenue of $18.66 million for the quarter, compared to analysts’ expectations of $17.30 million. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. Equities research analysts predict that Pro-Dex, Inc. will post 2 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Pro-Dex
A number of institutional investors have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey bought a new position in Pro-Dex during the second quarter worth $28,000. Los Angeles Capital Management LLC bought a new stake in Pro-Dex during the fourth quarter valued at $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Pro-Dex during the second quarter worth $50,000. AlphaQuest LLC acquired a new position in shares of Pro-Dex in the 3rd quarter valued at about $71,000. Finally, Bank of America Corp DE grew its position in shares of Pro-Dex by 173.3% during the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock valued at $74,000 after buying an additional 1,073 shares during the last quarter. 15.28% of the stock is currently owned by institutional investors.
About Pro-Dex
Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.
Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.
Featured Stories
- Five stocks we like better than Pro-Dex
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
